Search clinical trials for: AZD2516
Total 88 results
-
AstraZenecaCompletedStudy to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male SubjectsRefluxNetherlands, Belgium
-
AstraZenecaCompleted
-
AstraZenecaQuintiles, Inc.CompletedPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years. | Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80United Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Samsung Medical CenterWithdrawn
-
Massachusetts General HospitalUnited States Department of Defense; AstraZenecaCompletedMeningioma | Neurofibromatosis 2United States
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaCompletedAdvanced Solid TumoursUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); AstraZenecaActive, not recruiting
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaCompletedMild Cognitive Impairment | Mild Alzheimer's DiseaseUnited States
-
AstraZenecaCompleted
-
AstraZenecaWithdrawnHealthy VolunteersUnited Kingdom
-
AstraZenecaCompletedTourette SyndromeUnited States
-
Samsung Medical CenterWithdrawnSolid TumorKorea, Republic of
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
AstraZenecaCompleted
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompletedAdvanced CancerUnited Kingdom
-
AstraZenecaQuintiles, Inc.TerminatedNeuropathic Pain | Mechanical HypersensitivityUnited States
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
AstraZenecaCompleted
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
Canadian Cancer Trials GroupAstraZenecaCompletedGlioblastoma MultiformeCanada
-
AstraZenecaCompletedBrain Distribution of [11C]AZ12807110 and AZD5213Sweden
-
AstraZenecaCompleted
-
AstraZenecaCompletedTolerabilityUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung Disease Causing Persistent Narrowing of the AirwaysUnited Kingdom
-
AstraZenecaTerminatedHealthyUnited Kingdom
-
AstraZenecaCompletedPharmacokineticsUnited Kingdom
-
AstraZenecaActive, not recruiting
-
AstraZenecaCompletedPain | Diabetic NeuropathyUnited States
-
AstraZenecaCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy VolunteerUnited Kingdom
-
AstraZenecaCompletedCOVID-19 | SARS-CoV-2United Kingdom, Brazil, South Africa, Poland
-
Dizal PharmaceuticalsActive, not recruitingBreast Cancer MetastaticChina, United States
-
Samsung Medical CenterTerminatedCancer of StomachKorea, Republic of
-
Samsung Medical CenterTerminatedStomach NeoplasmsKorea, Republic of
-
Cambridge University Hospitals NHS Foundation TrustAstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownSquamous Cell Lung Cancer | Triple-Negative Breast Cancer | Non-squamous Cell Lung Cancer With KRAS Mutations | Non-squamous Cell Lung Cancer With Wild-type KRASUnited Kingdom
-
University Health Network, TorontoAstraZeneca; NeoGenomics LaboratoriesRecruitingLocoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)Canada